News

GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.

GlaxoSmithKline and Sanofi have delayed the expected rollout of their COVID-19 vaccine to the final months of 2021. Interim results for human studies showed an “insufficient response in older adults,” the drugmakers said Friday – but they praised its effects in other age groups. The companies plan to repeat a […]
GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.
News

Trump has a distant financial link to a pharma giant that makes the drug he’s been pushing to fight COVID-19 — but it’s probably worth less than $1,000

President Donald Trump has a distant financial link to Sanofi, the French pharmaceutical company that produces a drug that is being trialed as a possible coronavirus treatment The link was first highlighted by The New York Times, which described it as “small.” Calculations by Business Insider suggest the stake – […]
Trump has a distant financial link to a pharma giant that makes the drug he’s been pushing to fight COVID-19 — but it’s probably worth less than $1,000
News

Dispensed: Big Pharma’s plans to compete with buzzy startups, Sanofi’s entrance to the coronavirus vaccine race, and a Medicare Advantage pitch deck

Hello, Welcome to Dispensed, Business Insider’s weekly healthcare newsletter. This week’s edition is being written in sunny Palm Springs, California, though regrettably sent out back in chilly New York. Are you new to the newsletter?You can sign up here. The big story I want to highlight this week came from […]
Dispensed: Big Pharma’s plans to compete with buzzy startups, Sanofi’s entrance to the coronavirus vaccine race, and a Medicare Advantage pitch deck
News

Why insulin is so expensive

Colorado became the first state to pass a bill capping the monthly cost of insulin per resident at $US100. Type 1 diabetics need insulin to survive. Due to drastic price increases, many diabetics are struggling to afford the lifesaving drug. In the past 15 years, insulin prices have tripled. There […]
Why insulin is so expensive
Markets

Regeneron’s CEO has been outspoken about drug price hikes, but one of his company’s drugs just got more expensive

Regeneron’s CEO, Leonard Schleifer, once criticised arbitrary drug price increases by pharmaceutical companies. But in July, the company’s eczema drug price increased by 3%. Regeneron said Sanofi had final decision-making authority on pricing for the drug. Sanofi defended the price increase, saying it is below the rate of medical inflation […]
Regeneron’s CEO has been outspoken about drug price hikes, but one of his company’s drugs just got more expensive